Advanced search
Publication Cover
Scandinavian Journal of Gastroenterology Volume 58, 2023 - Issue 9
Submit an article Journal homepage
105
Views
1
CrossRef citations to date
0
Altmetric
Original Article

Plasma thymidine kinase activity as a prognostic biomarker in pancreatic ductal adenocarcinoma: a single-center prospective study

Ebba Asplunda Department of Upper Gastroenterology, Karolinska University Hospital Huddinge, Stockholm, Sweden;b Department of Clinical Science, Intervention, and Technology (CLINTEC), Karolinska Institutet, Stockholm, SwedenCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-7649-7901View further author information
ORCID Icon,
Mattias Bergqvistc Biovica International AB, Uppsala, SwedenORCID Iconhttps://orcid.org/0000-0002-0093-9443View further author information
ORCID Icon,
Maura Krooka Department of Upper Gastroenterology, Karolinska University Hospital Huddinge, Stockholm, Sweden;b Department of Clinical Science, Intervention, and Technology (CLINTEC), Karolinska Institutet, Stockholm, SwedenView further author information
&
J.-Matthias Löhra Department of Upper Gastroenterology, Karolinska University Hospital Huddinge, Stockholm, Sweden;b Department of Clinical Science, Intervention, and Technology (CLINTEC), Karolinska Institutet, Stockholm, SwedenORCID Iconhttps://orcid.org/0000-0002-7647-198XView further author information
ORCID Icon
Pages 1044-1048 | Received 27 Dec 2022, Accepted 28 Mar 2023, Published online: 11 Apr 2023

References

  • Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics, 2021. CA Cancer J Clin. 2021;71(1):7–33.
  • Ferlay J, Partensky C, Bray F. More deaths from pancreatic cancer than breast cancer in the EU by 2017. Acta Oncol. 2016;55(9-10):1158–1160.
  • Groot VP, Rezaee N, Wu W, et al. Patterns, timing, and predictors of recurrence following pancreatectomy for pancreatic ductal adenocarcinoma. Ann Surg. 2018;267(5):936–945.
  • Ryan DP, Hong TS, Bardeesy N. Pancreatic adenocarcinoma. N Engl J Med. 2014;371(11):1039–1049.
  • Kleeff J, Korc M, Apte M, et al. Pancreatic cancer. Nat Rev Dis Primers. 2016;2:16022.
  • Duffy MJ, Sturgeon C, Lamerz R, et al. Tumor markers in pancreatic cancer: a european group on tumor markers (EGTM) status report. Ann Oncol. 2010;21(3):441–447.
  • Bilici A. Prognostic factors related with survival in patients with pancreatic adenocarcinoma. World J Gastroenterol. 2014;20(31):10802–10812.
  • Jones S, Zhang X, Parsons DW, et al. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science. 2008;321(5897):1801–1806.
  • Yachida S, White CM, Naito Y, et al. Clinical significance of the genetic landscape of pancreatic cancer and implications for identification of potential long-term survivors. Clin Cancer Res. 2012;18(22):6339–6347.
  • Riva F, Dronov OI, Khomenko DI, et al. Clinical applications of circulating tumor DNA and circulating tumor cells in pancreatic cancer. Mol Oncol. 2016;10(3):481–493.
  • Martinez-Useros J, Garcia-Foncillas J. Can molecular biomarkers change the paradigm of pancreatic cancer prognosis? Biomed Res Int. 2016;2016:4873089.
  • Chen Y, Ying M, Hu M, et al. Serum thymidine kinase 1 correlates to clinical stages and clinical reactions and monitors the outcome of therapy of 1,247 cancer patients in routine clinical settings. Int J Clin Oncol. 2010;15(4):359–368.
  • Bjöhle J, Bergqvist J, Gronowitz JS, et al. Serum thymidine kinase activity compared with CA 15-3 in locally advanced and metastatic breast cancer within a randomized trial. Breast Cancer Res Treat. 2013;139(3):751–758.
  • Bagegni N, Thomas S, Liu N, et al. Serum thymidine kinase 1 activity as a pharmacodynamic marker of cyclin-dependent kinase 4/6 inhibition in patients with early-stage breast cancer receiving neoadjuvant palbociclib. Breast Cancer Res. 2017;19(1):123.
  • Felix K, Hinz U, Dobiasch S, et al. Preoperative serum thymidine kinase activity as novel monitoring, prognostic, and predictive biomarker in pancreatic cancer. Pancreas. 2018;47(1):72–79.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.